drugset / Trial / NCT00578929
Safety and Efficacy of Olopatadine HCl Nasal Spray in 6-11 Year Old Patients
RandomizedParallel-groupQuadruple-blindTreatment
Summary
A study to demonstrate the superiority of test article nasal spray relative to vehicle nasal spray for the treatment of seasonal allergic rhinitis for a 2 week period in patients aged 6 to 11 years with a history of seasonal allergic rhinitis.
Timeline
- Start
- 2007-09
- Primary completion
- 2008-11
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Olopatadine | Other / unclassified | 0.6 % | Intranasal |